The board of directors of Zhongzhi Pharmaceutical Holdings Limited announced the following changes to the Board with effect from 14 May 2018: Lai Ying Feng has been appointed as an executive Director and a member of the remuneration committee and a member of the nomination committee. Mr. Yang Ai Xing has been appointed as a non-executive Director. Mr. Lai, aged is the son of Mr. Lai Zhi Tian, an executive Director and Ms. Jiang Li Xia, a non-executive Director. He joined the Group since April 2014 and has served as the counter director, the director of the Huochuang division and the deputy director of the Hongguan division and brand center of Zhongshan Zhongzhi Pharmaceutical Group Co. Ltd., a subsidiary of the Company, taking charge of brand management, promotion and marketing activities. Since July 2016, Mr. Lai has also served as a director of that subsidiary, mainly responsible for organizing the formulation of business plan of the company, investment and financing plan, and making decisions on major issues. Mr. Lai has extensive experience in strategic management, marketing business management, team management, brand management and promotion, system building for regulation management and system building for process management, etc. He is particularly good at building, forging, and managing business teams. From October 1995 to January 2016, Yang served as the sales director, marketing director, vice president of marketing and group chief executive of Jiaduobao Holdings Limited. Since February 2016, he has been the managing partner of Shanghai Novich Positioning Investment Management Co., Limited.